Cargando…
WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025623/ http://dx.doi.org/10.1016/j.ekir.2023.02.1001 |
| _version_ | 1784909375882657792 |
|---|---|
| author | KLOCHKOVA, N. Lysenko, M. Zeltyn-Abramov, E. Poteshkina, N. Markova, T. Frolova, N. Belavina, N. Kondrashkina, S. |
| author_facet | KLOCHKOVA, N. Lysenko, M. Zeltyn-Abramov, E. Poteshkina, N. Markova, T. Frolova, N. Belavina, N. Kondrashkina, S. |
| author_sort | KLOCHKOVA, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10025623 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100256232023-03-21 WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS KLOCHKOVA, N. Lysenko, M. Zeltyn-Abramov, E. Poteshkina, N. Markova, T. Frolova, N. Belavina, N. Kondrashkina, S. Kidney Int Rep Covid-19 and CKD Published by Elsevier Inc. 2023-03 2023-03-20 /pmc/articles/PMC10025623/ http://dx.doi.org/10.1016/j.ekir.2023.02.1001 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Covid-19 and CKD KLOCHKOVA, N. Lysenko, M. Zeltyn-Abramov, E. Poteshkina, N. Markova, T. Frolova, N. Belavina, N. Kondrashkina, S. WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS |
| title | WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS |
| title_full | WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS |
| title_fullStr | WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS |
| title_full_unstemmed | WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS |
| title_short | WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS |
| title_sort | wcn23-0166 new onset renal replacement therapy is a predictor of covid-19 adverse outcome in patients with advanced chronic kidney disease due to type 2 diabetes mellitus |
| topic | Covid-19 and CKD |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025623/ http://dx.doi.org/10.1016/j.ekir.2023.02.1001 |
| work_keys_str_mv | AT klochkovan wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT lysenkom wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT zeltynabramove wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT poteshkinan wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT markovat wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT frolovan wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT belavinan wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus AT kondrashkinas wcn230166newonsetrenalreplacementtherapyisapredictorofcovid19adverseoutcomeinpatientswithadvancedchronickidneydiseaseduetotype2diabetesmellitus |